Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cancer Medicine|November 28, 2020
Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancerHala T Borno, Tracy Kuo Lin, Anobel Y Odisho, et al.
Frontiers in Oncology|November 16, 2020
Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional CohortPedro Barata, Whitley Hatton, Arpita Desai, et al.
JCO Oncology Practice|December 21, 2021
Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate CancerDaniel H Kwon, Sneha Karthikeyan, Alison Chang, et al.
World Journal of Translational Medicine|December 20, 2014
Epithelial ovarian cancer: An overviewArpita Desai, Jingyao Xu, Kartik Aysola, et al.
Cancer Medicine|November 21, 2024
Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate CancerDaniel H Kwon, Lauren Trihy, Nika Darvish, et al.
Cancer|March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancerDaniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Urologic Oncology|November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracersDaniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
The Oncologist|March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate CancerMeredith N Freeman, Albert Jang, Jason Zhu, et al.
The Lancet. Oncology|November 3, 2023
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trialRahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Journal for Immunotherapy of Cancer|March 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0Rana R McKay, Archana Ajmera, Michael B Atkins, et al.
Pageof 3